NCT01242072View on ClinicalTrials.gov

Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies

PHASE1UnknownINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
MalignancyCancerNon Small Cell Lung CancerSmall Cell Lung CancerTesticular CancerThymomaOvarian CancerOsteosarcoma
Interventions
DRUG

palifosfamide-tris

Intravenous on days 1, 2 and 3 of each 21-day cycle for up to 4 cycles

Trial Locations (4)

46202

Indiana University Simon Cancer Center, Indianapolis

47303

Medical Consultants, PC, Muncie

47905

Horizon Oncology Research, Lafayette

63110

Washington University, St Louis

Sponsors
All Listed Sponsors
lead

Alaunos Therapeutics

INDUSTRY